Shailesh Siroya For and on behalf of Promoter and Promoter Group of the Company has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shailesh Siroya, acting on behalf of the promoter and promoter group of Bal Pharma Limited, has submitted a disclosure to the exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to file yearly disclosures confirming their shareholding status and compliance with the creeping acquisition limits. The filing is a routine regulatory compliance submission and does not indicate any change in ownership or any transaction. No specific share quantity, price, or stake change details are mentioned in the filing.
This is a routine compliance filing required of all listed promoters and is unlikely to have any material impact on the stock price or shareholder interests. Investors should watch for any follow-up disclosures that provide actual shareholding numbers.